BIOARCTIC AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.7 SEK | +1.50% |
|
-8.00% | -26.55% |
| Apr. 15 | Nordic Shares Moved Upward Monday; Invisio Led Increases | DJ |
| Apr. 12 | Nordic Stocks Rose Friday; BioArctic Series B Climbed Highest | DJ |
Chart calendar BioArctic AB
bf3b94532ac2d997de.MQjz2-u-gTirX4zNfIYVugBahxnNNZgy0J8lwF0x6c0.AXqKqrza2VPIJur0JsR-72E86m-bVtlcivtzrG1HjqRaOcW2uunxSfsR2Q~3ff3cf9e2dc977ecc42d2c50efd402a8
Upcoming events on BioArctic AB
Past events on BioArctic AB
| 2024-03-09 04:25 am | Alzheimer and Parkinson Diseases International Conference - Structural dynamics of amyloid-? protofi |
| 2024-03-09 04:10 am | Alzheimer and Parkinson Diseases International Conference - Lecanemab for the treatment of early Alz |
| 2024-03-09 03:40 am | Alzheimer and Parkinson Diseases International Conference - Binding characteristics of lecanemab, do |
| 2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation : P0111 / #943 |
| 2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation P0110 / #562 |
| 2024-03-07 | Alzheimer and Parkinson Diseases International Conference - Presentation P0213 / #1510 |
| 2024-03-07 10:20 am | Alzheimer and Parkinson Diseases International Conference - Novel approaches to clinical development |
| 2024-03-07 08:50 am | Alzheimer and Parkinson Diseases International Conference - Treatment with lecanemab disrupts tau ac |
| 2024-03-07 06:10 am | Alzheimer and Parkinson Diseases International Conference - Defining meaningful benefits to patients |
| 2024-03-04 | Alzheimer and Parkinson Diseases International Conference |
| 2024-02-14 03:30 am | Q4 2023 Earnings Call |
| 2024-02-14 02:00 am | Q4 2023 Earnings Release |
| 2024-02-05 11:08 pm | Q4 2023 Sales and Revenue Release |
| 2023-11-08 03:30 am | Q3 2023 Earnings Call |
| 2023-11-08 02:00 am | Q3 2023 Earnings Release |
| 2023-11-06 11:16 pm | Q3 2023 Sales and Revenue Release |
| 2023-10-26 02:50 pm | Clinical Trials on Alzheimer Disease Conference |
| 2023-10-25 05:05 pm | Clinical Trials on Alzheimer Disease Conference |
| 2023-10-23 | Clinical Trials on Alzheimer Disease Conference - LP011Impact of a Site Supplemental Funding Program |
| 2023-10-23 | Clinical Trials on Alzheimer Disease Conference - P045ARIA by Clinical Subgroup and Baseline Amyloid |
Past dividends on BioArctic AB
| 2019-05-09 | Annual 1.5 SEK |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 714 261 173.17% | 282 294 -4.07% | 65,9 57,6 14.46% | 23,1 121 -80.83% | 230 220 4.71% | 616 559 10.2% |
|
EBITDA Million SEK | Released Forecast Spread | 491 85,0 477.47% | 122 71,6 70.05% | -74,0 -152 51.22% | -127 -60,2 -110.39% | -2,81 -10,5 73.25% | 271 277 -2.06% |
|
EBIT Million SEK | Released Forecast Spread | 489 87,0 461.84% | 113 72,3 55.54% | -85,0 -151 43.69% | -140 -59,5 -134.88% | -17,4 -78,1 77.68% | 253 264 -4.42% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 490 88,0 456.36% | 113 72,2 56.52% | -86,7 -152 42.92% | -141 -60,3 -132.92% | -11,2 -34,1 67.22% | 276 209 32.35% |
|
Net income Million SEK | Released Forecast Spread | 382 69,0 453.04% | 88,5 56,4 57.03% | -68,5 -142 51.78% | -120 -60,3 -98.66% | -11,2 -64,6 82.7% | 229 183 25.1% |
|
EPS SEK | Released Forecast Spread | 4,33 0,78 455.13% | 1,00 0,64 56.25% | -0,78 -1,31 40.63% | -1,36 -0,68 -99.12% | -0,13 -0,72 81.84% | 2,59 2,09 24.22% |
| Announcement Date | 14/02/19 | 06/02/20 | 04/02/21 | 03/02/22 | 03/02/23 | 14/02/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 2,75 3,00 -8.47% | 209 119 75.49% | 11,0 15,9 -30.67% | 18,2 | 311 | 52,1 | 65,5 | ||
|
EBIT Million SEK | Released Forecast Spread | -101 -94,0 -7.31% | 131 23,0 469.62% | -78,1 -67,8 -15.19% | -81,8 | 195 | -74,9 | -82,0 | ||
|
Net income Million SEK | Released Forecast Spread | -44,3 | 294 | |||||||
|
EPS SEK | Released Forecast Spread | -0,50 | 3,31 | -1,16 -0,98 -18.37% | 1,41 2,00 -29.5% | -0,99 -0,90 -10% | -0,80 | 2,20 | -0,50 | -0,50 |
| Announcement Date | 28/04/22 | 27/04/23 | 12/07/23 | 08/11/23 | 14/02/24 | - | - | - | - |
More events
Past sector events for BioArctic AB
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
- Calendar BioArctic AB
